3 completed, 1 not yet recruiting, 1 terminated. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Human Papillomavirus Infections: new trials by email Literature Review of Human Papillomavirus Infections trials Research Report on Human Papillomavirus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV) Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections | Not applicable | Not yet recruiting | Hifas da Terra S.L. | 81 | 2027-07-01 | 2026-10-05 |
| Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix Ad26.HPV16, Ad26.HPV18, MVA.HPV16/18 - Human Papillomavirus Infections | Phase 1 / Phase 2 | Terminated | Janssen Vaccines & Prevention B.V. | 9 | 2018-09-27 | 2025-02-04 |
| ICI-VPH: Impact of HPV Immunisation Schedules Against HPV Quadrivalent HPV vaccine - Human Papillomavirus Infections | Phase 3 | Completed | CHU de Quebec-Universite Laval | 3364 | 2013-11-01 | 2022-04-28 |
| Genital HPV Infections Before and After Renal Transplantation Human Papillomavirus Infections | Completed | University Medical Center Nijmegen | 65 | 2012-02-01 | 2016-10-25 | |
| GARDASIL™ Vaccine Impact in Population Study (V501-033) Human Papillomavirus Infections | Completed | Merck Sharp & Dohme LLC | 54516 | 2007-05-29 | 2022-09-13 |
Papillomavirus Infections (5) · Atypical Squamous Cells of the Cervix (1) · Congenital Abnormalities (1) · Squamous Intraepithelial Lesions (1)
Communicable Diseases (5) · DNA Virus Infections (5) · Disease Attributes (5) · Genital Diseases (5) · Infections (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Sexually Transmitted Diseases (5) · Sexually Transmitted Diseases, Viral (5) · Tumor Virus Infections (5) · Urogenital Diseases (5) · Virus Diseases (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)
CHU de Quebec-Universite Laval (1) · Hifas da Terra S.L. (1) · Janssen Vaccines & Prevention B.V. (1) · Merck Sharp & Dohme LLC (1) · University Medical Center Nijmegen (1)
Belgium (1) · Canada (1) · Netherlands (1) · Spain (1) · United States (1)
Joanne A de Hullu, MD, PhD (1)
PMID 24552678, PMID 32990181, PMID 40627355, PMID 41276263
2018 (1)